SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001072613-22-000138
Filing Date
2022-02-11
Accepted
2022-02-11 16:57:41
Documents
1
Group Members
ARCH VENTURE FUND X OVERAGE, L.P.ARCH VENTURE PARTNERS X OVERAGE, L.P.ARCH VENTURE PARTNERS X, L.P.ARCH VENTURE PARTNERS X, LLCKEITH CRANDELLKRISTINA BUROWROBERT NELSENSTEVEN GILLIS

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND X, L.P. - EQRX, INC. -- SCH 13G arch-sch13g_18587.htm SC 13G 291140
  Complete submission text file 0001072613-22-000138.txt   292961
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 773-380-6600
ARCH Venture Fund X, L.P. (Filed by) CIK: 0001757011 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Subject) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93138 | Film No.: 22622291
SIC: 2834 Pharmaceutical Preparations